Russia is investing 2 trillion RUB into a national health project to develop the world's first anti-aging gene therapy. Targeting the RAGE receptor, the initiative aims to slow biological decay and combat population decline. Officials expect production to begin by 2030, marking a significant shift toward biotechnology and enhanced longevity.